Software - ANVISA Registration 81464750181
Access comprehensive regulatory information for Software in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81464750181 and manufactured by PERIVISION S.A.. The registration is held by Domo Salute Consultoria Regulatória Ltda with validity until currently active (VIGENTE).
This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including PHILIPS MEDICAL SYSTEMS NEDERLAND B.V., CARDIO SISTEMAS COMERCIAL E INDUSTRIAL LTDA, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Janaina dos Santos de Miranda
🇧🇷 Brazil Regulatory Expert
Need help with your Brazil registration?
Contact Pure Global Brazil TeamDevice Details
Registration Details
81464750181
25351060831202548
26263959000103
Company Information
Dates and Status
Jun 02, 2025
VIGENTE
09/18/2025 19:00:01
Software
SOFTWARE ONEPACS
ONEPACS, LLC
80102519047
Dec 08, 2014
SOFTWARE FOR MEDICAL IMAGE PROCESSING
OPTIX ONE
Optix Imagens Medicas LTDA - EPP
81733870001
May 16, 2019
Software
REVITALVISION
REVITALVISION, LLC
80469980001
Apr 11, 2011
Software
ViewPoint 6
GE HEALTHCARE GMBH
80071260192
Dec 10, 2012
Software
OneConnect
MPS TECNOLOGIA E SERVIÇOS LTDA
82984310002
Feb 24, 2025
Software
Calculadora VDZ-CDST
TAKEDA PHARMACEUTICALS U.S.A., INC.
80147410026
Sep 15, 2025
Software
P4C
DEDALUS ITALIA SPA
81806320006
Sep 15, 2025
Software
AFOOT AI
LOOKINSIDE SERVICOS E TECNOLOGIAS LTDA
83126510001
Sep 08, 2025
Software
MV PEP
MV SISTEMAS DE MEDICINA DIAGNOSTICA LTDA
80436840006
Sep 08, 2025
Software
Future Fertility Oocyte Software
FUTURE FERTILITY INC.
83084440002
Aug 18, 2025